Artérite temporale juvénile : une maladie bénigne
M. Carreiro, P. Arlet(Hôpital Rangueil), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), A. Oksman(Laboratoire d'Aérologie), S. Dahan, L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), Nathalie Margarit-Coll
Cited by 4
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138
Acute interstitial nephritis related to immune checkpoint inhibitors
|British Journal of Cancer|2016|103